Estrella Immunopharma Inc. Financial Flexibility Index
Estrella Immunopharma Inc. financial flexibility index. Estrella Immunopharma Inc. (ESLA) has a Financial Flexibility Index of -0.19x as of June 2026. Free cash flow of $-1.78 Million (operating CF $-1.78 Million minus capex $0.00) represents 0% of total liabilities ($9.26 Million).
Financial Flexibility Index
Free Cash Flow
Total Liabilities
Capital Expenditures
Financial Flexibility Index of Estrella Immunopharma Inc. (2021–2025)
Financial flexibility index of Estrella Immunopharma Inc. from 2021 to 2025. Historical Financial Flexibility Index trend for Estrella Immunopharma Inc. across 5 annual periods. Explore Estrella Immunopharma Inc. (ESLA) debt coverage ratio to assess how comfortably operating cash covers total debt obligations.
Estrella Immunopharma Inc. Financial Flexibility Index by Year (2021–2025)
Estrella Immunopharma Inc. financial flexibility index by year from 2021 to 2025. Year-by-year free cash flow to debt coverage for Estrella Immunopharma Inc.. For the full cash flow conversion analysis, see Estrella Immunopharma Inc. cash flow conversion.
| Year | Flexibility Index | Free Cash Flow (USD) | Operating CF | Total Liabilities | YoY Change |
|---|---|---|---|---|---|
| 2025 | -0.13x | $-1.79 Million | $-1.79 Million | $13.54 Million | ▲ +87.3% |
| 2024 | -1.04x | $-3.11 Million | $-3.11 Million | $3.00 Million | ▲ +98.8% |
| 2023 | -88.92x | $-16.07 Million | $-16.07 Million | $180.70K | ▼ -24738.1% |
| 2022 | -0.36x | $-1.04 Million | $-1.04 Million | $2.92 Million | ▼ -48.0% |
| 2021 | -0.24x | $-1.44 Million | $-1.44 Million | $5.96 Million | — |